Back to company

NBCD A/S: Financial statements 2017

CVR: 30582462

NBCD A/S (CVR 30582462) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 24,576,095 and a net result of DKK 20,785,529 compared with DKK 13,977,615 the year before. That is an increase of 93% compared with the year before. Equity amounted to DKK 21,500,588. The solvency ratio was 23.7%.

Gross Profit
24,576,095 kr.
Profit/Loss
20,785,529 kr.
Equity
21,500,588 kr.
Total Assets
90,661,157 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-24.6 mio.20.8 mio.21.5 mio.-
2016-12.7 mio.14 mio.9.7 mio.-
2015--6.1 mio.37.9 mio.44.2 mio.-
2014-1.6 mio.29.2 mio.6.3 mio.-
2013--3.4 mio.-11.8 mio.-22.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like NBCD A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

NBCD A/S: The 2016 annual report is outJun 2, 2017

NBCD A/S has published its annual report for 2016. Gross profit came to DKK 12,735,938, and the net result was DKK 13,977,615.

About NBCD A/S

NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The company is owned by Sanos Holding A/S. The company has 24 employees. In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity amounted to DKK 136,144,994.